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Abstract--The operational mechanics of a novel drug release implant capsule are 
formulated in terms of a one-dimensional Stefan moving boundary diffusion problem. 
Computational solutions for this are obtained using Meyer's numerical technique, and 
a complementary open-form analytical solution applicable to constant drug impreg- 
nations is obtained by a perturbation method. A similarity solution pertaining to a 
particular boundary condition is also given. The question of attaining apredetermined 
drug release-rate/time characteristic by the introduction of a spatially variable drug 
impregnation is also considered. 
1. INTRODUCTION 
In a novel method for long-term drug administration u der development, a polydimethyl- 
siloxane (silicone rubber) capsule impregnated with the appropriate drug is implanted in 
animal or patient. The drug then enters the subject's ystem by molecular diffusion from 
the capsule at a rate which depends on the impregnation concentration a d other factors. 
In some applications the capsule is implanted subdermally. For this purpose, it is 
frequently in the form of a circular od. Another possibility is that it may be employed as 
a vaginal insert for long-term contraceptive purposes. In this application, the device is 
typically cylindrical or toroidal in shape and delivers an ovulation inhibiting drug such as 
medroxyprogesterone ac tate. The earliest in vitro experimental study of the drug 
release characteristics of these devices appears to be due to Roseman and Higuchi [1]. 
Subsequently a considerable amount of experimental work has been carried out 
concerning their in vitro behaviour and the correlation of this to the function in vivo, for 
example [2-7]. 
So far theoretical investigations of the drug release properties of these capsules have 
been approximate and employ a simplified mathematical formulation of the diffusion 
process involved in the dispersal of the drug. Principally it is assumed that there exists a 
"pseudo-steady-state" distribution of concentration i the drug depleted region which 
forms below the surface of the capsule during the release process. This approximation is 
only appropriate when the concentration of drug impregnated in the capsule rubber is 
considerably in excess of its solubility in this material. Additionally, mathematical 
approximations a suming this condition have also been employed. By using this simple 
formulation, Higuchi [8] investigated the drug release from a plane surface and from a 
spherical pellet, in the so called "matrix controlled" situation where the concentration i  
the surface of the capsule is held constant. Roseman and Higuchi [l] also employed a
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similar approach in their analysis of the "matrix/boundary diffusion" case where the flux 
of drug dispersing from the capsule surface is determined by the positive difference 
between the concentration at the surface of the capsule and that of the surroundings. 
Their investigation considered the cases of both planar and cylindrical capsules and it 
was noted that for up to 50% of the total drug release a plane surface is a good model for 
a cylindrical capsule. This, and other, work is reviewed by Flynn, Yalkowski, and 
Roseman [9]. An exact solution of the drug release process is of some theoretical 
interest. For arbitrary stable drug impregnation concentrations in excess of its solubility 
in the capsule material, this has a proper mathematical formulation in terms of the 
classical Stefan moving boundary problem. This general formulation does not appear to 
have been reported. Simple forms of this problem also arise in other biomedical 
situations. One is Oudin's method using in vitro diffusion of antigen for the assay of 
antigen concentration [10]. This process has been studied theoretically by Onishi, 
Sugihara, and Tanaka [11]. 
The theory of the Stefan moving boundary problem is considered by Crank [12], and 
extensively discussed by Rubenstein [13]. A number of situations in heat flow and 
diffusion which involve moving boundaries have been investigated recently [14]. In the 
context of the Stefan problem, the matrix controlled case considered by Higuchi is an 
example of a boundary value problem of the first kind [15]. An exact closed-form 
analytical solution to this problem is available. Because the results of this have not been 
applied in the theoretical study of the drug release process we give these below. The 
"matrix/boundary diffusion" case considered by Roseman and Higuchi [1] belongs to the 
class of boundary value problems of the second kind. This problem has no analytical 
solution in closed-form. Below we present an open-form parametric analytical solution 
to this problem which is thought o be new. To complement this, exact numerical 
solutions have been obtained using the technique proposed by Meyer [16]. Some of these 
are displayed in this paper. 
Recently there has been some interest in the construction of a device which will 
deliver drug at a uniform rate throughout i s active life. Brooke and Washkuhn [17] 
proposed a design of capsule which was intended to achieve this objective. However, a 
theoretical nalysis of the behaviour of the device, properly considering the finite nature 
of its dimensions [18], has shown that constant release rate is only approached after a 
large time has elapsed. In this connection the problem has been posed (R. van Noort, 
personal communication) as to whether a capsule can be constructed which has a release 
rate which is a prescribable function of time by introducing into the capsule a spatially 
variable distribution of the impregnated drug. This question is also considered below. 
2. FORMULATION OF THE PROBLEM 
Motivated by the above discussion we consider the one-dimensional nonsteady 
problem of release of drug from the plane surface of a drug impregnated matrix X I> 0. 
The drug release behaviour of this is identical to that of a single plane surface of a planar 
capsule of thickness 2a for times T, 0 ~< T ~< ~', where z is defined below. It is assumed 
that mass transport is by molecular diffusion through the matrix and that this, rather than 
drug dissolution, is the transport rate limiting factor. 
The mass concentration of impregnated drug and its saturated solution concentration 
(solubility) in the matrix are denoted by C, cs, respectively, with C > cs. Both are 
regarded as being prescribed quantities which, in the most general case, will depend on 
the distance X from the surface and the time T. Since mass transport is only possible if 
the drug is in solution in the matrix the drug release proceeds by the formation from the 
surface X = 0 of a drug depleted layer 0 ~ X ~< A in which the concentration c(X, T) <~ cs. 
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Fig. 1. Concentration zones and schematic concentration distribution i drug release process. 
As the release process evolves the plane X = A advances into the matrix. This is the 
moving boundary. The situation is shown in Fig. 1. The time ~" for a planar capsule is 
defined by a = A(~'). 
In the depleted layer, the concentration satisfies the nonsteady one-dimensional 
diffusion equation 
0% 1 ac 
= D 0T' (2.1) 
where D is the effective coefficient of diffusion of drug in the matrix and is considered to 
be constant. At X = A, the concentration i  the depleted layer attains its maximum 
allowable value so that 
c(A, T) = cs. (2.2) 
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The rate of drug release - J  from a unit area of the surface is 
- J=  D a~-~)o+, (2.3) 
where the subscript 0+ indicates evaluation i  the depleted layer at X = 0. 
It is supposed that the device is bathed by a large volume of well-stirred aqueous 
solution X ~ 0. In what follows, we take the bulk concentration cB of this to be zero. 
There is no loss of generality in this choice since if it is desired to assign ca a nonzero 
constant value, all other concentrations may be regarded as elevations above this level. 
In this bathing liquid, a stagnant layer of constant thickness h forms at the surface X = 0 
across which drug transport occurs by diffusion. In this the nonzero concentration 
satisfies Eq. (2.1) with D replaced by Da, the ditIusivity of drug in aqueous olution. The 
concentrations c+, c_ of drug in the capsule and stagnant layer at X = 0 are related by 
C_ 
Kp = - -  (2.4) 
C+' 
where Kp is the partition coefficient for drug in aqueous and silicone rubber phases. 
To obtain a boundary condition for the behaviour at the capsule surface a knowledge 
of the concentration distribution in the stagnant layer is required. This distribution is 
coupled to the unknown time dependent concentration i the capsule depleted layer 
through Eq. (2.4) and consequently is unknown. To consider the diffusional behaviour in 
the stagnant layer, Eq. (2.1) is expressed in the form 
a2c h 2 
OT*' (2.5) 
by the introduction of nondimensional length and time variables 
X *=X T* T 
h-' Tc' (2.6) 
where Tc is a characteristic process time. The choice Tc = 1 day (86,400 sec) appears to 
be appropriate for the drug release applications described in Sec. 1, which have capsule 
operation times extending over several days, 25 days being a typical value. From 
experiments on impregnated silicone rubber cylinders in a stirred aqueous solution 
Roseman and Higuchi [1] estimated h as 6.68 × 10 -3 cm and calculated Da for medroxy- 
progesterone acetate in water as 6.54 x 10 -6 cm 2 sec -1. For these data, h2lD,~ has the value 
6.823 sec and, with the above choice for To h21(D,~Tc)= 7.897 × 10 -5. The alternative 
choice T~ = 1 h gives h2/(DaTc) ---1.895 x 10 -3. These calculations suggest that for times 
T I> To where fractional changes in (oc/aT*)[c are expected to be of the order of unity 
or smaller, the approximation of the right-hand side of Eq. (2.5) by zero will be 
satisfactory. Then the concentration distribution i  the stagnant layer is of a quasisteady 
form. In terms of dimensional independent variables, this distribution, which satisfies the 
concentration a d mass flux continuity conditions 
ac 
c = c_, -D.  ~= J at X =0_, (2.7) 
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at the capsule surface, is 
J (T )  
c(X, T) = c_(T) - ~ X. (2.8) 
Then by combining Eq. (2.8) with Eqs. (2.3), (2.4) and the condition 
c=0 at X=-h  (2.9) 
for zero bulk concentration of drug in the capsule bathing liquid, it is found that at the 
surface X -- 0 the concentration i  the depleted layer satisfies the condition 
a--q--c = Kc at X=O+, 
aX 
where (2.10) 
K = D,,Kp 
Dh"  
In the investigation of Roseman and Higuchi Kp was determined to be 0.033 and 
D = 2.6 x l0 -7 cm 2 sec -1. Then the associated value of K is 124.26 cm -~. 
It remains to establish the condition satisfied at the moving boundary. This is effected 
from the mass conservation consideration that the total mass of drug abstracted from the 
matrix per unit surface area is equal to the time integral of the surface flux. This requires 
that 
fo A ff  ac ) (C - c) dX = D ~ (X, T) dr. 0+ (2.11) 
By integrating Eq. (2.1) with respect o X between limits 0, A the result 
DaC'~ = D OC ~ _ (A ac 
OX]o+ OX/x=A Jo aT dX 
(2.12) 
is obtained. The combination of this with (2.11) yields, after differentiation with respect 
to T and use of (2.2) 
A OC "X dA Oc 
fo -~-~a +(C-¢s ) -~-~= D-~)x= A. (2.13) 
It is envisaged that time dependence of C may occur if the impregnated rug has 
chemical instability or is subject o bacterial degradation. In such cases the motion of the 
moving boundary is described by the integrodifferential equation (2.13). When these 
effects are absent so that OC/OT - 0, (2.13) reduces to 
dA D Oc ) 
d-T=C - cs0-X X=A' (2.14) 
and satisfies 
A=O at T=O.  (2.15) 
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Thus, it is seen that for the case of time independent concentrations of impregnated drug 
with which we are particularly concerned the variation of drug concentration i the 
depleted layer is formulated in terms of a Stefan moving boundary problem by Eqs. 
(2.1), (2.2), (2.10), (2.14), and (2.15). The boundary value problem defined by these 
equations i well-posed and has a unique solution [15]. For a planar capsule this solution 
exists for 0 ~< T ~< ~'. For times T i> r, the drug release problem is formulated in terms of 
the classical diffusion problem with fixed boundaries in which the "initial" concentration 
distribution is c(X, "r) (0 <~ X <~ 2a) and c(2a - X, T) = c(X, T). 
3. ANALYTICAL SOLUTIONS FOR CONSTANT SOLUBILITY AND DRUG 
IMPREGNATION 
The situation where the solubility and the concentration f impregnated drug are both 
constant is of particular interest. This is the case which has been studied previously. The 
solution obviously depends on the diffusion layer parameter ~ as well as the other 
physical quantities. For indefinitely large values of K with bounded surface concen- 
tration gradient, Eq. (2.10) reduces to a fixed surface concentration condition. In this 
event, an exact closed form analytical solution is available. This is given first. Examina- 
tion of its structure suggests a form for an expansion solution applicable when K is finite. 
3.1. Similarity solution for K --, o~ (matrix controlled case) 
In this case the surface boundary condition is 
c=0 at X=0 (3.1) 
and Eqs. (2.1), (2.2), (2.14), (2.15) and (3.1) have the similarity solution 
where/3 is the solution of 
c(X, T) = cs 
erf/3 
A(T) = 2/3X/DT, 
= E 
/3 eO2erf/3 X/~' 
(3.2) 
with (3.3) 
Cs 
E=C_Cs" 
(Figure 2 shows a graph of/3 as a function of E). The instantaneous release rate from a 
unit area of surface is found from (2.3), (3.2)t, and (3.3) and is 
- J = /3 e~2(C - cs )4~,  (3.4) 
and the time integral of (3.4) gives the total drug released after a time T per unit surface 
area of the capsule as 
Q = 2/3 e~2(c  - Cs)X/-D--T. (3.5) 
1.5 
I.O 
0.5  
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Fig. 2 Variation of/3 with • [Eq (3.3)d 
From Eqs. (3.2)2 and (3.5) it is seen that the thickness of the depleted layer and the drug 
released are both proportional to T t/2. These results are exactly true for all values of 
C > cs. These properties have also been derived previously from approximate analyses 
[1, 8, 9]. Graphs of the concentration profile predicted by Eqs. (3.2) for various values of 
e are shown in Fig. 3.I' The nondimensional release-rate 
- J  
and the nondimensional drug release 
Q 
( C - cs)~/2eDT 
are plotted in Fig. 4 as a function of E. The factor containing %/~ in the denominators of 
these quantities ensures that they are both of order unity. 
For sufficiently small values of e, Eq. (3.3)~ has the open-form inversion 
(3.6) 
Also it is evident from inspection of (3.2) that c/cs is expressible as a function of/3(e) 
and the similarity variable X/A.  The expansion of this function in a series of powers of e 
tThe reasons for selecting these • values are given at the beginning of Sec. 5. 
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is 
_=_  ~ e2 (9X4 X2_19 ) . }. c X [1 (1 - ~-:~) + 3-- ~ ~-a-+ 10-~-r + " 
Cs A +6 
(3.7) 
Further, from Eqs. (3.4), (3.5), and (3.6), the results 
- J  Q : (1+~_ 11 2+. . .}  
(C_c, )X/~T=(C-c , )X/2,DT 3 180 
(3.8) 
are obtained. The term in Eq. (3.7) which is independent of E is the "pseudo-steady-state" 
distribution assumed in earlier investigations. By retaining only the two lower-order 
terms in Eqs. (3.6), (3.8)2 and by using (3.2)2, (3.3)2 the results 
( c'I./2Dc T 
A = \ ~v-O- -F ,  
2 C-~cs~ 
Q : ~/X /2c ,D(C  - G)T 
(3.9) 
are obtained and are correct o 0(¢3/2). These differ from the formulae 
.] 2Dc~T 
A= ----V- 
~C -~cs 
Q = X/2csD(C-~c,)T 
(3.10)t 
given by Higuchi [8] and Flynn, Yalkowski, and Roseman [9] for the "matrix controlled 
case." This is because Eqs. (3.10) were derived by manipulating two expressions for the 
mass of drug released into solution in the drug depleted layer by the movement of the 
boundary X = A. One of these relations involves only zeroth-order quantities and is 
correct to that order, the other is an approximate xpression and involves first-order 
quantities. When C >> c, both Eqs. (3.9) and (3.10) are approximated by 
]2c~DT (3.11) A=~¢ ~- , 
Q = x/2Cc:DT. (3.12) 
3.2. Perturbation solution [or finite K (matrix/boundary diffusion case) 
It is clear that the reciprocal boundary diffusion parameter K -~ is the only constant 
quantity appearing in Eqs. (2.1), (2.2), (2.10), (2.14), (2.15) which has dimensions of 
length. This suggests the introduction of the nondimensional position x and the non- 
tEquations (3.10) are expressed in the notation of the present investigation. This differs from the original 
form in some respects. 
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dimensional depleted layer thickness X 
x=KX,  A=KA.  (3.13) 
In association with (2.28) the nondimensional time scale and concentration measure 
t = EK2DT, E = c__ (3.14) 
Cs ' 
arise naturally. Then the introduction of these substitutions transform the above listed 
equations into 
O2g OC" 
-~x~=~-~ O~x~X(t ) , t>O,  
OE 
E=I  at x=X,  ~=E at x=O,  (3.15) 
) -d-i Ox x=~ )~=0 at t=0,  
which do not involve K. However, when the solutions for c, A obtained by solving Eqs. 
(3.15) are expressed in terms of X, T they must reduce to Eqs. (3.2) in the limit as K ~oo. 
From examination of Eqs. (3.2), it is expected that the solution to Eqs. (3.15) could be 
expressed in the parametric form 
= e(x, X, E), t = t(X, E), (3.16) 
and inspection of Eqs. (3.2)2, (3.6), (3.7) suggests that this solution might be obtained in 
the regular perturbation series 
C=C0+E~t+E2~2 +' ' ' ,  t=t0+~h+E2t2+ " ' ' .  (3.17) 
This approach is similar to a method proposed by Ockendon [19] for the solution of a 
heat conduction problem involving state changes. A solution to that problem was sought 
as an asymptotic expansion in reciprocal powers of a large latent heat parameter. This 
occurs in the moving boundary equations in the same manner as does E -I in the present 
problem. In that case, however, difficulties concerning lack of uniform validity were 
encountered which do not arise in the present investigation. 
After Eqs. (3.17) are substituted into Eqs. (3.15), some straightforward analysis leads 
to the results 
e = c = x + 1 + E {x2(x + 3)(x + 1) - x2(x + 3)(x + 1)} 
cs x + 1 6(x + 1) 4 
+ c2 {9(h + 1)[x4(x + 5)(h360(X + +1) 1) 7- A4(A + 5)(x + 1)] 
10A(A2+ 3A + 12)[x2(x + 3)(h + 1) - h2(h + 3)(x + 1)] 1 + +.  (3.18) 360(A + 1) 7 / o o 
t=eK2DT=() t+ l )  2 +~-~+. . -  
1 3(X + 1) 9(X + 1) 4 " + --~+E + +.  • • 
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The term in Eq. (3.18)1 which is independent of • is the "pseudo-steady-state" concen- 
tration distribution assumed by Roseman and Higuchi [1]. By rewriting Eq. (3.18)~ in 
terms of X, A and evaluating the limit as K ~ ~ it is found that Eq. (3.7) is recovered as 
required. The (t, h) relation of Eq. (3.18)2 is readily inverted as the perturbation series 
(3 o6 6-' 6 -2 6 -3+86-' X( t )=th- l+ , ,  (-4~+34~-1-24~-2)+•2~ 12 9 815 18 ] 
(3.19) 
where 4~(t) = X/1 + 2t. Again by rewriting Eq. (3.19)t in terms of A, T and evaluating the 
limit as K ~ it is found that Eq. (3.2) is recovered in which /3 is given by Eq. (3.6). 
Further it is easily seen that as • ~0,  Eqs. (3.18)1 and (3.19)1 reduce to 
c x+l  
h = X/]~ 2t - 1. (3.20) 
cs  /1-VS' 
This is termed the zeroth order approximation. Equation (3.20)2 is deducible directly 
from a result given in [1]. 
A formula for the calculation of the drug release rate per unit surface area can be 
derived by using Eqs. (2.3), (2.10), (3.13), (3.18)1, and (3.19). After some manipulation it is 
found that this is conveniently expressed in the nondimensional form 
J~(t)Dc~ K= 1 +3 (1 - 4~-2+_  2q~-3) + •2(, 180114> -23+~4~2 -3 +~b9 -4_ ]-~ 4 52 -5 +]_~25 ~b_6) +. . . ,  
(3.21) 
which is analogous to Eq. (3.8)1 and, when expressed in terms of T, reduces to that 
equation in the limit as • ~.  The evaluation of Eq. (3.21) at t = 0 (~b = 1) confirms the 
expectation suggested by physical considerations that the initial release rate is 
- J(O) = Drc ,  (3.22) 
which is independent of the concentration C of impregnated drug. 
Because the time integral of - J  gives Q, the total drug released per unit surface area 
up to the current time, the use of this integral together with Eq. (3.21) facilitates the 
derivation of a formula for the calculation of Q. This is conveniently written in the 
nondimensional form 
QK 
(C - cs)(cb(t) - 1) 
2 
6-,)2 • =1+~(1-  + l~( - l l - l l~b- l+49~-z+29~b-3-106~-4+50~-5)+. . .  
(3.23) 
which is analogous to Eq. (3.8)2. This equation is recovered from (3.23) in the limit as 
Graphs showing the variation of the nondimensional concentration e = c/cs in the 
depleted layer with nondimensional distance x for various nondimensional times for 
several values of e are shown in Figs. 5, 6 and 7. These have been constructed from Eqs. 
(3.18)1 and (3.19). Also included in the figures is the concentration variation predicted by 
the similarity solution, Eqs. (3.2) of Sec. 3.1. In these, and other, figures this is indicated 
by broken lines. This presentation is possible because the similarity solution can be 
expressed in terms of the nondimensional variables x, t, ~t without the explicit ap- 
pearance of the diffusion layer parameter K. In Figs. 8, 9, and 10 the variation of the 
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( ) second-order perturbation solution [Eq. (3.19)1; (. . . . . .  ) similarity solution [Eq. (3.2)21; (OO©) 
exact numerical solution. 
Drug therapeutics 355 
nondimensional position A of the moving boundary as a function of nondimensional time 
t calculated from Eq. (3.19) is shown for various values of e. Also contained in the 
figures is the variation predicted by Eq. (3.2)2 of the similarity solution. 
In order to display the variation of the drug release rate and the total drug released as 
functions of nondimensional time in Figs. 11, 12, and 13, and Figs. 14, 15, 16, respec- 
tively, the quantities --(J/DcsK) and QM(C- G) are shown plotted as functions of t for 
various values of e. These are calculated from Eqs. (3.21) and (3.23). Closed-form 
analytical formulae for these quantities may also be obtained from the similarity solution 
by rewriting Eqs. (3.4) and (3.5) in terms of t. After slight rearrangement, these equations 
yield the results 
J 1 
DCsK = X/~/3 e~:t -tn, 
QK _ 2 e~:t,/2 
C - cs  /3 " 
(3.24) 
The variation of -(J[DcsK) and QK/(C- G) predicted by Eqs. (3.24) are also displayed 
on the figures. 
In order to assess the accuracy of these analytical solutions and to investigate to what 
range of values of e the open-form solutions are applicable xact numerical solutions for 
the various quantities have been computed using the technique described in the follow- 
ing section. Results obtained by using this method are also shown in Figs. 5-16 by 
hollow circles. 
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Fig. 11. Variation of nondimensional drug release rate per unit surface area - J[Dc~K with nondimensional time 
t for • =~.  ( ) second-order perturbation solution [Eq. (3.21)l; ( . . . . . .  ) similarity solution lEq. 
(3.24)t]; (© © O) exact numerical solution. 
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Fig. 12. Variation of nondimensional drug release rate per unit surface area -]/Dc,K with 
nondimensional time t for ~ = I. ( ) second-order perturbation solution [Eq. (3.21)]; (. . . . .  -) similarity 
solution [Eq. (3.24)d; (O O O) exact numerical solution. 
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Fig. 13. Variation of nondimensional drug release rate per unit surface area - ] lDc,•  with nondimensional time 
t for ~ = 2. ( ) second-order perturbation solution [Eq. (3.21)]; ( -  . . . .  -) similarity solution [Eq. 
(3.24)1]; (O O O) exact numerical solution. 
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Fig. 14. Variation of nondimensional total drug released per unit surface area QK/(C - cs) with nondimensional 
time t for e = ~.  ( ) second-order perturbation solution [Eq. (3.23)]; ( . . . . . .  ) similarity solution [Eq. 
(3.24)2]; (O O O) exact numerical solution. 
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Fig. 15. Variation of nondimensional total drug released per unit surface area QK/(C - c,) with nondimensional 
time t for • = 1. ( ) second-order perturbation solution [Eq. (3.23)]; ( . . . . . .  ) similarity solution [Eq. 
(3.24)2]; (O O O) exact numerical solution. 
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Fig. 16. Variation of nondimensional total drug released per unit surface area QK/(C - c,) with nondimensional 
time t for • = 2. ( ) second-order perturbation solution [Eq. (3.23)]; ( . . . . . .  ) similarity solution [Eq. 
(3.24)2]; (© O ©) exact numerical solution. 
4. NUMERICAL  SOLUTION OF THE MOVING BOUNDARY DIFFUSION 
EQUATIONS 
For the numerical solution, the transformation 
~=l -u  (4.1) 
is incorporated in the governing equations (3.15), which then have the form 
32u 3u 
-~-rx -E~-=0,  O~x~;~(t),t>O, 
0U+l  at x=0,  u=ax 
dX+au=0 at x=~,  u = 0 and ~ ax 
A =0 at t=0.  
(4.2) 
Equations (4.2) are a particular case of more general equations considered by Meyer [16] 
and the approach adopted here is based on Meyer's method of straight lines. By 
discretising the time variable Meyer shows that the problem (4.2) may be approximated, 
in part, by a sequence of initial value ordinary differential equation problems. Using the 
suffix k to denote quantities associated with the kth time-level, from Eqs. (4.2) we obtain 
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the system of ordinary differential equations to be solved: 
E 
w',,(x) = 1 - ~ [Wk(x) ]  2, Wk(0)  = 1 
E W'k(X) = ---~ Wk(X)[Wk(X)- Uk-I(X)], Wk(0) = 1 (4.3) 
E 
v',,(x) = ~ [Wk(X)Vk(X ) + Wj,(X) -- Uk_,(X)] ,  Vk(Xk ) = -- Wk(Xk)/Wk(Xk). 
Here h is the time-step between the (k-1) th  and kth time-levels and uk_](x) is an 
approximation, assumed known, to the solution of Eqs. (4.2) on the (k - 1)th time-level. 
The boundary distance ~k may be obtained as the solution ~ of the nonlinear equation 
(~ -- hk-1) /h  -- Wk(~)/  Wk(~)  = 0, (4.4) 
where ~k_l is assumed known, and the required approximation to the solution of Eqs. 
(4.2) at the (new) kth time-level may be obtained from 
ul,(x) = Wk(X)Vk(X) + Wk(X). (4.5) 
In deriving (4.3), (4.4), and (4.5) from (4.2), the backward ifference approximations 
(~tt )k ~" Uk(X)-- 
have been used for the discretised time-derivatives. If we let 
m 
F(y) -= cosh(0y) + 0 sinh(0y), 
G(y) -= 0 cosh(0y) + sinh(0y), 
the solutions of Eqs. (4.3) are, respectively, 
Wk(X) = G(x)/[OF(x)], 
and 
where 
Vk(X) = F(x)[vk(~k)/F(,~k) + O2 f~i {Wk(r)-- Uk-l(r)}/F(r) dr ], 
Vk(Xk) = -- Wk(XO/Wk(Xk), 
(4.6) 
(4.7) 
(4.8) 
(4.9) 
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and Eq. (4.4) may be converted to the form 
(~: h )~k-~) G(~) - K = 0 
= G(r)uk- l ( r )  
(4.10) 
It is assumed, in deriving (4.10), that 
uk-l(x) =- 0 for x > Xk-~. 
(4.11) 
For the problems considered in this paper, it is always true that )tk > )kk-t. Hence, if a 
value for hk_~ and values for uk_~(x) for x = O, H,  2H. . .  mk- tH  have been calculated, 
where H is the mesh-length (space-step) in the x direction and mk- iH  <)~k-~ << - 
(rnk-~ + 1)H, then the boundary position, )tk, at the kth time-level is found by solving the 
nonlinear equation (4.10) for ~, using the Newton-Raphson second-order iterative 
process. Having determined Ak, and using (4.11)2, Eq. (4.8) provides values for wk(x) for 
x = O, H,  2H.  . . mkH andx=i~k. 
Combining Eqs. (4.7) and (4.9) gives 
Wk(X)Vk(X) = G(x)  - Wk()tk)/G()tk) + 0 (wk(r)-- uk- l ( r )}/F(r )  dr  , 
k 
which, using previously computed results and (4.11)2, provides values for Wk(X)Vk(X) for 
X = O, H,  2H. . .  mkH. Equation (4.5) then gives the required solution values for uk(x). 
This procedure is now repeated, using the currently calculated values for )tk and Uk(X), 
X = O, H . . .  mkH,  to obtain )~k+l, Uk+l(X), X = 0, H, 2H. . .  mk+lH, and so on. 
At the start of the process, to determine )tl and u~(x), the procedure is simplified 
because A0 = 0. Here At is obtained as the solution ~ of 
and then the equations 
~G(~) 0 = 0, (4.13) 
h 
wl(x )  = l / F (x ) ,  
Wl (x )v l (x )  = G(x) [FOtO lGOtO-  G(x ) /F (x ) ] / (O  2 -  1), 
(4.14) 
combine with Eq. (4.5) to yield u~(x). 
The computer program implementing the described calculation procedure is written in 
ALGOL 68 and results have been produced, for a wide range of values for e, using the 
Sheffield University ICL 1906S computer. The integration values needed in Eqs. (4.10), 
(4.8), and (4.12) are computed by the extended Trapezium Rule with, in the initial stage, 
a small space-step H. However, as k increases the boundary distance )rE increases and, in 
order to reduce computing time and storage space requirements whilst maintaining 
accuracy, the space-step H is doubled for the (k + 1)th time step, provided that error 
estimates for the integrals (over the maximum range for r) computed uring the kth time 
step give estimated relative errors satisfying a preset olerance. Again, for efficiency, a
test is made after each time step calculation to determine whether the time-step h should 
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be changed and, in addition, the more accurate approximation for (dMdt)k, namely, 
(~t)k  1 1 1 hk-l+ 1 hk-2], (4.15) 
= h [~k - )tk-1] + h [1 - -~ ~k - "O(1 + "O) 
instead of (4.6)2, is incorporated in (4.10)1. In (4.15), as usual, h is the time-step between 
the (k - 1)th and kth time-levels and "oh ('O = 0.5, 1, or 2) is the time-step between the 
(k -  2)th and (k -  1)th time-levels. Hence, in the program, (4.10)1 is replaced by 
~ LI__~_~  _ 1  F2+  l+~rl hk-i q" r/(1 + "O~-----)l Ak-2]G(~)- K =0 (4.16) 
where K is given by (4.10)2. The test is achieved by calculating the magnitude of the 
ratio of the second term in (4.15) to the whole of (4.15), and, if this magnitude is less than 
a small preset tolerance h is doubled for the next step, or, if it is greater than another 
larger preset olerance h is halved; otherwise h remains unchanged. 
Finally, it should be noted that the adapted Meyer method described in this section is 
extremely stable and the corresponding program produces accurate results with 
moderate demands on both computer time and storage. 
5. DISCUSSION OF RESULTS 
The solutions presented in Fig. 3 and Figs. 5-16 are for the cases e = 1/300, 1, 2. 
These values were selected in view of the following considerations. In the intravaginal 
I contraceptive devices described in Sec. 1 characteristically E ~ 1, and the value E -  3oo 
1 (and other values of E < ~ have been employed in in vitro trials. In a projected applica- 
tion for short-term post-operative antibiotic delivery in the treatment of hydrocephalus a 
value ~ ~ 1 is anticipated. The perturbation expansion becomes increasingly inaccurate 
for values of ~ > 1 and the case E = 2 clearly illustrates its limitations. The results for 
this case are also presented to allow for possible future developments in pharmaceutical 
applications. 
From Figs. 5, 6, and 7 it is seen that, in accordance with physical expectation, the 
concentration of dissolved drug in the depleted layer increases monotonically with 
distance into the layer, the width of which increases moothly with time. This latter 
feature is also evident from Figs. 8, 9, and 10. The concentration gradients and surface 
concentrations fall monotonically with increasing time. For sufficiently small E, the 
distribution is sensibly linear. Additional results, not given here, showed that near- 
linearity was obtained with E ~< ~. From Figs. 11, 12, and 13 the release-rate is seen to fall 
rapidly with time initially and for small times (up to t = 5). For the larger time values 
considered (30 < t < 50) the rate of fall is very slow and the nondimensional release rate 
-J/DcsK has values around 0.1. This behaviour is a consequence of the diminishing 
speed of the depleted layer/impregnation region interface and is responsible for a 
diminution of the curvature of the cumulative drug release/time characteristic with 
increasing time. This is evident in Figs. 14, 15, and 16. 
With regard to the accuracy of the analytical solutions, an inspection of Figs. 5, 8, 11, 
and 14, which are each for the case ~ = ~,  reveals that the second-order perturbation 
solution provides results which are in complete agreement with those derived from the 
numerical solution. For the case E = 1, shown in Figs. 6, 9, 12, and 15, there is again very 
good agreement between the two solutions, particularly in Figs. 12 and 15. From Fig. 6 it 
is clear that the second-order perturbation solution is excellent for all x when t is small 
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(up to t ~ t0)t and for small x (up to x ~ 2) for larger values of t (up to t = 8t0) and that 
the maximum relative error in ~ is approximately 5%. A similar situation exists in Fig. 9 
where the perturbation and numerical solutions are very close for times up to t = 25 (i.e., 
t ~-4t0) and the maximum relative error in A is about 3%. Hence, we conclude that the 
second order perturbation solution is perfectly satisfactory for all values of ~ up to 
unity. This has been confirmed by producing the corresponding results (not displayed 
1 here) for the intermediate values E = ~,  ~,  ~5, ~, ~ for which, as expected, the differences 
between the perturbation and numerical solutions increase steadily from the negligible 
1 discrepancies at e = ~ to those stated for e = 1. The results for ~ = 2 are shown in Figs. 
7, 10, 13, and 16. For this case it is seen that the perturbation solution deviates 
significantly from the numerical solution (except in Fig. 13 for sufficiently large times) 
and gives rise to maximum relative errors of the order of 19%, 16%, 10%, and 12%, 
respectively. As a consequence it is suggested that unless such errors are considered 
tolerable the perturbation solution should not be used for values of E greater than unity. 
The broken lines in Figs. 5-16 obtained using the similarity solution show that when 
compared with the numerical solution the former yields results which, in general, are 
much inferior to those obtained from the perturbation solution. The graphs of depleted 
layer concentration i  Figs. 5, 6, and 7 show that the constraint ~= 0 at x = 0 for all t is 
responsible for the significant discrepancies, for the range of time values considered, of 
the similarity solution. However, Fig. 7 shows that for large E (i.e., e ~ 2) as t increases, 
and at sufficiently large distances into the capsule, this solution gives rather better esults 
than the perturbation solution. This behaviour is also observed in the moving boundary 
position-time graphs in Figs. 8, 9, and 10. Figures 11, 12, and 13 show that, except for 
the initial instant, the instantaneous release rate-time relationship calculated from the 
similarity solution is a good approximation to that obtained from the numerical solution, 
particularly for t > 20. However, the former solution is unbounded at t = 0 and this gives 
rise to appreciable rrors in the early stages of the release process. This phenomenon is 
also responsible for the nearly constant differences between the graphs shown in Figs. 
14, 15, and 16 of cumulative drug release against ime obtained from the two solutions. 
In addition to the preceding comments we also mention two observations concerning 
results not presented here which were calculated using solutions given in Sec. 3. First, as 
expected, it has been found that, for sufficiently small ~, the zeroth order perturbation 
approximation [Eqs. (3.20)] produces results which are in close agreement with both the 
numerical and second order perturbation solutions. In the particular case E = ~,  the 
results for which are presented in Figs. 5, 8, and 11, the agreement is almost complete. 
Second, results corresponding to the second-order perturbation solution have also been 
obtained by using only Eqs. (3.18)1,2 to calculate concentration values in the depleted 
layer. This was effected by substituting the required E and t values into Eq. (3.18)2 and 
solving this equation for )t numerically using the Newton-Raphson iterative scheme. In 
general, the changes in the accuracy of the results produced by this more complicated 
procedure are minimal but for large E (the particular case e = 2 was studied in detail) it 
provides better approximations to the numerical solution for the depleted layer concen- 
tration and moving boundary position than do Eqs. (3.18)t and (3.19). 
6. CONTROLLABILITY OF THE DRUG RELEASE-RATE 
In this final section, we investigate the theoretical possibility of the construction of a 
device which has a drug release-rate which is a specified function of time, by introducing 
tt0 denotes the value t = 5.78 and is chosen so that in a pharmaceutically interesting case in which E = ---~, to 
is equivalent to 5 days. 
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into the matrix particular controlled spatial variations of solubility and impregnation 
concentration. We do not consider here whether it is possible to achieve a predetermined 
release-rate from a device with a matrix of complex geometrical form. That is the basis 
of the design of Brooke and Washkuhn [17] mentioned in Sec. I. 
Suppose that 
- J = 0(T ) ,  (0  > 0), (6.1) 
is the desired release-rate/time characteristic of a device which has impregnation 
concentration C(X) and solubility c~--F(X), which are time independent. (A more 
general case might be envisaged in which these quantities vary with time but for 
simplicity the effect is neglected here.) The problem is to determine suitable com- 
binations of C(X), F(X)> 0 which allow the prescribed 0(T) to be achieved and have 
associated solutions which are compatible with the obvious physical requirements of
positive depleted layer concentration a d nondecreasing depleted layer thickness. 
It follows from Eqs. (2.3), (2.10), and (6.1) that a solution for c(X)  (0<X <A(T)) in 
which the desired release-rate is achieved will have 
1 c(0, T) = ~-~ 0(T). 
(6.2) 
Thus, it is clear that the concentration c(X)  of drug in the depleted layer is obtained as 
the solution to the inverse Stefan problem of which the general form is 
O2c 1 ac 
for 0 < X < A(T) 
DOT' 
c = f (T)  
ac 
a---X = g(T) 
at X = 0 VT, (6.3) 
c=F(A(T)) at X=A(T)  VT 
where 
dA D Oc ) 
d~ = C(A)- F(A) ~ X=A' A(0) = 0 
in the particular case where 
1 
g(T) = KI(T) = --~ 6(T). (6.4) 
An exact analytical solution to this problem is not available and solutions for the 
Laplace transformations of the variables do not appear to be of assistance with the 
present application. However, as remarked in Sec. 5, the numerical solution for constant 
C, cs and for stepwise variable C (see Fig. 18) shows that for C ~> cs the spatial 
concentration distribution in the depleted layer is sensibly linear and, for constant C, c, 
(C ~> c,), the solution is adequately represented by the zeroth order terms of the 
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perturbation expansion [Eqs. (3.20)]. Thus in connection with the current question we 
generalise this observation to apply to sufficiently small arbitrarily variable cJC > 0 and 
take 
c(X, T)= D-'(X + I)qj(T), (6.5) 
as the approximate solution for the concentration i the depleted layer. Equation (6.5) 
satisfies conditions (6.3)2,3 and in employing this generally we disregard the nonsteady 
diffusion equation (6.3)1 of the governing system. 
The combination of Eq. (6.5) with Eqs. (6.3)4,5 then yields 
F(A)= D-I(A + 1)qj(T), 
d__TT = C(A)_D- , (A+I  ) T(0)=0, 
dA qJ(T) 
(6.6) 
from which, for prescribed O(T), any pair of the triplet C(A), F(A), T(A) is determined if 
the third is specified. "Suitable" specification gives 
dT C(A) > 0, F(A) > 0, T(A) > 0, ~ > 0 
for certain A > 0. Except if tk is constant, one possibility is to prescribe F(A) and regard 
Eq. (6.6)1 as determining T(A). Then the substitution of this into Eq. (6.6)2 yields the 
distribution C of impregnated drug required to achieve the desired release-rate with the 
selected F. Alternatively, if C(A) is specified T(A) is determined from the first-order 
ordinary differential equation which results from Eq. (6.6)2. In general, this will be 
nonlinear and a numerical solution may be required. The use of this solution together 
with Eq. (6.6)1 determines the associated F. Finally, if the moving boundary is chosen to 
have a particular motion F, C are determined irectly from Eqs. (6.6)1,2. 
There is certain interest in the construction of a device from which the release-rate is 
constant. In considering this case, we denote 
0(T) = R = constant (6.7) 
and observe that in this circumstance, Eq. (6.5) is an exact solution of Eq. (6.3h. Then it 
follows from Eq. (6.6)1 that a constant release rate is achievable only if the solubility has 
the linear distribution 
c ,=F(x)=R(x+ 1) (6.8) 
for any distribution of impregnated rug C -> F. In this case, the form of C(A) does not 
affect the release-rate characteristic and only influences the behaviour of the device 
through its effect on the temporal variation of the moving boundary. When C = Co is 
constant, this motion is given by 
De0, 4( 0 2 _ 2DT (6.10) A(T) = R K 
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which is formally valid for 
When 
the moving boundary reaches the place, if in a finite device it exists, where the solubility 
and impregnation concentration are equal. For subsequent times, the problem is not of 
the moving boundary type. 
In pharmaceutical practice, the introduction of a controlled istribution for C, at least 
in fine stepwise form is a feasible procedure. However,  difficulties may be encountered 
in producing controlled distributions of solubility of drug in the matrix. Because of this 
the case of constant solubility is also of certain interest. To investigate this case, we 
denote 
F(A) = c~ = constant (6.11) 
and find from Eq. (6.6)1 that 
Dc~ 1 (6.12) 
A(T )= 6(T)  K" 
It follows from Eq. (6.12) that for dA/dT >0,  with bounded C(X), only release-rates 
which decrease monotonically with time are achievable. This deduction was anticipated 
from consideration of the physics of the moving boundary process. By substituting Eq. 
(6.12) into Eq. (6.6)2 it is found that O(T) is determined from 
d ~b _ ~b 3 
dT  Dc~(C(A(T) )  - c~)' 
(6.13) 
and for the case where C is also constant the zeroth-order term in Eq. (3.21) is 
recovered. 
To investigate the effect that a stepwise variation in drug impregnation has on the 
characteristics of a device of constant solubility we have considered a situation in which 
C increases by uniform steps as the distance from the surface increases. The actual 
variation chosen is shown in Fig. 17. Only one half of the device is considered. The drug 
concentration values are typical for medroxyprogesterone ac tate employed in the in- 
travaginal contraceptive devices described in Sec. 1. Additionally, we have used the 
associated value c~ = 0.1 mg cm -3 and the data D = 2.6 × 10 -7 cm 2 sec -~, K = 124.26 cm -~ 
mentioned in Sec. 2. 
In principle, the solution for this variable impregnation concentration case is effected 
in a similar manner to that described in Secs. 3 and 4 for constant C. However,  in such 
more general cases, we define 
Cs (6.14) 
• max{C(X)}-  cs 
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Fig. 17. Stepwise spatial distribution C - c, mg cm -3 of impregnated drug considered in model problem of Sec. 
6 (c, = 0. l mg cm-3). 
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Fig. 18. Variation of nondimensional concentration 6 = c/¢~ in the depleted layer with nondimensional distance 
x for the given nondimensional times t at which the moving boundary reaches the locations of the dis- 
continuities in C (see Fig. 17). 
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Fig. 19. Variation of nondimensional position of moving boundary ,~ with nondimensional time t. The solid 
circles (O) indicate the times, shown in Fig. 18, at which the moving boundary reaches the discontinuities in C. 
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Fig. 20. Variation of nondimensional drug release rate per unit surface area - J/DcsK with nondimensional time 
t. The solid circles (0) indicate the times, shown in Fig. 18, at which the moving boundary reaches the 
discontinuities in C. 
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Fig. 21. Variation of nondimensional total drug released per unit surface area Qrl[max{C(X)}-cs] with 
nondimensional time t. The solid circles (0) indicate the times, shown in Fig. 18, at which the moving boundary 
reaches the discontinuities in C. 
and note that as a consequence of this a known function of x is introduced into Eqs. 
1 (3.15)4 [or (4.2)4] of the governing equations. In the particular case considered E --y~. For 
simplicity, only the exact numerical solutions for depleted layer concentration, moving 
boundary position, release rate and cumulative drug delivered have been computed using 
a simple modification of the method described in Sec. 4. For ease of comparison with the 
results for the constant impregnation case, the results for stepwise variable C are 
presented in terms of the nondimensional variables x, t, ~, ~,, - J]DcsK defined in Sec. 3 
and QK/[max{C(X)}- c~]. 
Figure 18 shows the spatial distribution of dissolved drug in the depleted layer at the 
times t = 0.720, 3.561, 10.149, 21.348, and 39.795 at which the moving boundary reaches 
the locations of the discontinuities in C. At all times, this distribution is highly linear. 
This motivated the use, when E ~ 1, of the approximate concentration distribution of Eq. 
(6.5) in the analytical investigation of the controllability of the release-rate. The temporal 
variation of the moving boundary is shown in Fig. 19. This is of similar form to that 
observed for the uniform impregnation case, but exhibits discontinuities in its pro- 
pagation speed at the above noted times. The places on the graph where this occurs are 
indicated in Fig. 19 (and also in Figs. 20 and 21) by solid circles. The release-rate/time 
characteristic of the device is displayed in Fig. 20. Comparison of this with Fig. 11 shows 
that the stepwise variation in impregnation concentration has modified the behaviour 
from the constant C case in that there is a more rapid initial fall in the release rate which 
is followed by drug release at an almost constant rate. The graph of cumulative drug 
delivered as a function of time shown in Fig. 21 reflects this behaviour and comparison of 
this with Fig. 14 shows that after a high early drug dose the cumulative delivery is more 
linear in time than when C is constant. The feature of high initial dose rate followed by a 
nearly constant maintenance dose may be of advantage in certain medical therapeutic 
situations. It is thought hat by careful design of the impregnation distribution this effect 
could be modified or accentuated. Also it appears to be possible to remove the initial 
high rate of drug delivery by the impregnation into the outer layers of the matrix of a 
therapeutically inactive substance (placebo) of similar diffusional characteristics to the 
medication. In this way a nearly constant release-rate/time-delay device would be 
obtained. These possibilities might be suitably considered in a future investigation. 
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